In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
批准号:
10608077
负责人:
Martin S. Pavelka
金额:
$19.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-04-11 至 2024-03-31
关键词:
AcidsAddressAllelesAmphibiaAnimal ModelAntibiotic ResistanceAntibiotic TherapyB-LymphocytesBacteriaBiological AssayBreathingBronchiectasisBurkholderia cepaciaChronicChronic lung diseaseComparative BiologyCystic FibrosisDevelopmentDiseaseEmbryoEmbryo ResearchExhibitsFertilizationFlow CytometryGene MutationGenesGenetic DeterminismGenus MycobacteriumHistologyHomologous GeneHumanImmuneImmune responseImmune systemImmunityImmunocompetentImmunocompromised HostInfectionInterferonsInvestigationKnock-outKnockout MiceLabelLaboratory OrganismLeukocytesLiverLower respiratory tract structureLungLung diseasesLung infectionsMacrophageMammalsMicrobial BiofilmsMicroscopyModelingMorphologyMulti-Drug ResistanceMusMycobacterium abscessusMycobacterium marinumMyeloid CellsPathogenesisPathogenicityPathologyPatientsPhenotypePositioning AttributePrevalenceProductionProliferatingPseudomonas aeruginosaRefractoryResearch ProposalsResistanceRoleSkinSoilSystemT-LymphocyteTadpolesTissuesTransgenic OrganismsVirulence FactorsVisualizationWaterXenopusXenopus laevisZebrafishadaptive immunityarmcell envelopechronic infectionemerging pathogengenome annotationhost colonizationhuman diseasehuman tissueimmunopathologyin vivoinsightintravital microscopylung pathogenmutantnon-tuberculosis mycobacterianovelpathogenpreventpromoterrespiratory pathogenresponsetranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Owing to its increasing prevalence, persistence, multidrug resistance, pathogenicity and treatment
challenges, the non-tuberculosis mycobacterium (NTM) Mycobacterium abscessus (Mab) has become a
serious threat to humans with chronic lung diseases such as bronchiectasis and cystic fibrosis, as well as
immunocompromised patients. However, Mab is still understudied compared to other pathogenic
mycobacteria. In addition, there is a limitation in current animal models that poses a real challenge for
investigating the respective roles of two Mab morphotypes, smooth (S) and rough (R), in lung
immunopathology, persistence and host immune response. The clearance of Mab in immunocompetent and
even immunocompromised mice prevent the study of chronic infection, and while for zebrafish embryos are
instrumental for investigating Mab infection, they cannot be used to model a pulmonary infection and T cell
involvement. Thus, there is a need for complementary animal models. Since like zebrafish embryos, X. laevis
tadpoles are transparent, allowing visualization of pathogen dissemination, but that in addition they do have
functional lungs and exhibit an immune system including T cells remarkably similar to humans, we propose to
develop a X. laevis tadpole model of Mab infection that mimics human pulmonary disease. Relying on an
established comparative biology approach to study immunity to mycobacteria in tadpoles and our recent
demonstration that both S and R Mab morphotypes readily infect tadpoles, disseminate in tadpole lungs and
persist up to 50 days, the objective of the exploratory research proposal is to investigate in vivo for over 40
days Mab persistence, and immuno-pathogenesis. Specifically, to address the hypothesis that persistent R
Mab is more actively proliferating and immunopathogenic than S Mab in X. laevis tadpoles we propose:
, by comparing
the host immune response and persistence of R and S Mab in the lung and other tissues using intravital
(1) Characterize immune-pathogenesis in tadpole lungs during persisting Mab infection
microscopy flow cytometry and transcriptomics as well as fluorescently labeled Mab and transgenic tadpoles
with fluorescent macrophages.
(2) Investigate the relevance of S to R morphotype switch in vivo for pathogenesis and persistence
, by
using a promoter system to control the S to R switch following infection and examining effect of switches on
persistence, pathogenicity and host immune response.
(3) Investigate genetic determinants of Mab immune-pathogenesis
, using selected Mab deletion
mutants generated by allelic exchange of Mab-specific genes as well as gene homologs shared by Gram-
negative lung pathogens.
We anticipate that novel insights relevant to human will be gathered. Our collaborative team is uniquely
positioned to carry these studies due to our background and complementary expertise.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
-
批准号:10350750
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2022
-
负责人:Martin S. Pavelka
-
依托单位:
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
-
批准号:10203747
-
项目类别:
-
资助金额:$44.15万
-
财政年份:2018
-
负责人:Martin S. Pavelka
-
依托单位:
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
-
批准号:10431963
-
项目类别:
-
资助金额:$44.15万
-
财政年份:2018
-
负责人:Martin S. Pavelka
-
依托单位:
New tools for studying M. abscessus pathogenesis
-
批准号:8814644
-
项目类别:
-
资助金额:$27.35万
-
财政年份:2015
-
负责人:Martin S. Pavelka
-
依托单位:
New tools for studying M. abscessus pathogenesis
-
批准号:9107388
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2015
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:8079716
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:8296659
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:7629629
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:7888312
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:7531380
-
项目类别:
-
资助金额:$39.58万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Genetic screens to identify mycobacterial porins
-
批准号:7497121
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2007
-
负责人:Martin S. Pavelka
-
依托单位:
Genetic screens to identify mycobacterial porins
-
批准号:7204287
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2007
-
负责人:Martin S. Pavelka
-
依托单位:
Identification of secreted proteins important for tularemia pathogenesis
-
批准号:7267993
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2006
-
负责人:Martin S. Pavelka
-
依托单位:
Identification of secreted proteins important for tulremia pathogenesis
-
批准号:7146725
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2006
-
负责人:Martin S. Pavelka
-
依托单位:
Development of genetic tools for Francisella tularensis
-
批准号:6665998
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2003
-
负责人:Martin S. Pavelka
-
依托单位:
Development of genetic tools for Francisella tularensis
-
批准号:6776437
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2003
-
负责人:Martin S. Pavelka
-
依托单位:
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
-
批准号:6259328
-
项目类别:
-
资助金额:$23.26万
-
财政年份:2000
-
负责人:Martin S. Pavelka
-
依托单位:
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
-
批准号:6612993
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2000
-
负责人:Martin S. Pavelka
-
依托单位:
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
-
批准号:6532810
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2000
-
负责人:Martin S. Pavelka
-
依托单位:
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
-
批准号:6374472
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2000
-
负责人:Martin S. Pavelka
-
依托单位:
海外基金